Yilmaz T - Search Results

1

Orbital Implants Receiving Food and Drug Administration Premarket Notification.

Corcoran Ruiz KM, Vaishnav YJ, Desautels J, Schaefer JL, Migliori ME, Yilmaz T. Corcoran Ruiz KM, et al. Among authors: yilmaz t. Ophthalmic Plast Reconstr Surg. 2022 Sep-Oct 01;38(5):503-506. doi: 10.1097/IOP.0000000000002228. Epub 2022 Jun 14. Ophthalmic Plast Reconstr Surg. 2022. PMID: 35699217

2

Discontinuation and nonpublication of interventional clinical trials conducted in ophthalmology.

Yilmaz T, Gallagher MJ, Cordero-Coma M, Gealy D, Loporchio S, Padula WV, Loporchio D, Statler B, Migliori M. Yilmaz T, et al. Can J Ophthalmol. 2020 Feb;55(1):71-75. doi: 10.1016/j.jcjo.2019.06.007. Epub 2019 Aug 13. Can J Ophthalmol. 2020. PMID: 31712042

3

The application of the retraction watch database in eye research-based studies.

Barton AT, Cordero-Coma M, Gallagher MJ, Yilmaz T. Barton AT, et al. Among authors: yilmaz t. Indian J Ophthalmol. 2021 Dec;69(12):3767. doi: 10.4103/ijo.IJO_2293_21. Indian J Ophthalmol. 2021. PMID: 34827044 Free PMC article. No abstract available.

4

Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic review.

Yilmaz T, Cordero-Coma M, Gallagher MJ. Yilmaz T, et al. Eye (Lond). 2012 Feb;26(2):252-8. doi: 10.1038/eye.2011.296. Epub 2011 Nov 18. Eye (Lond). 2012. PMID: 22094296 Free PMC article. Review.

5

Adjunctive globe magnetic resonance imaging in the diagnosis of posterior scleritis.

Cordero-Coma M, García-Morán A, Yilmaz T, Sánchez-Campos S, Calleja-Antolín S, Martín-Escuer B, Martin S, Ruiz de Morales JG. Cordero-Coma M, et al. Among authors: yilmaz t. Can J Ophthalmol. 2011 Aug;46(4):329-32. doi: 10.1016/j.jcjo.2011.06.009. Epub 2011 Jul 7. Can J Ophthalmol. 2011. PMID: 21816252

6

Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review.

Yilmaz T, Cordero-Coma M. Yilmaz T, et al. Graefes Arch Clin Exp Ophthalmol. 2012 Jun;250(6):787-93. doi: 10.1007/s00417-012-2016-6. Epub 2012 Apr 27. Graefes Arch Clin Exp Ophthalmol. 2012. PMID: 22539192 Review.

7

Triamcinolone and intraocular sustained-release delivery systems in diabetic retinopathy.

Yilmaz T, Cordero-Coma M, Lavaque AJ, Gallagher MJ, Padula WV. Yilmaz T, et al. Curr Pharm Biotechnol. 2011 Mar 1;12(3):337-46. doi: 10.2174/138920111794480598. Curr Pharm Biotechnol. 2011. PMID: 20939800 Review.

8

Treatment of severe non-infectious uveitis in high-risk conditions (Part I): pregnancy and malignancies, management and safety issues.

Cordero-Coma M, Salazar-Méndez R, Yilmaz T. Cordero-Coma M, et al. Among authors: yilmaz t. Expert Opin Drug Saf. 2015 Jul;14(7):1071-86. doi: 10.1517/14740338.2015.1044969. Epub 2015 May 7. Expert Opin Drug Saf. 2015. PMID: 25950807 Review.

9

Moving forward in uveitis therapy: preclinical to phase II clinical trial drug development.

Salazar-Méndez R, Yilmaz T, Cordero-Coma M. Salazar-Méndez R, et al. Among authors: yilmaz t. Expert Opin Investig Drugs. 2016;25(2):195-214. doi: 10.1517/13543784.2016.1128893. Epub 2015 Dec 30. Expert Opin Investig Drugs. 2016. PMID: 26640977 Review.

10

Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema.

Yilmaz T, Cordero-Coma M, Federici TJ. Yilmaz T, et al. Expert Opin Drug Metab Toxicol. 2011 Oct;7(10):1327-35. doi: 10.1517/17425255.2011.606215. Epub 2011 Jul 27. Expert Opin Drug Metab Toxicol. 2011. PMID: 21790508 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

546 results

Search Page

Filters